Tag:
Heptares Therapeutics
Latest Headlines
Latest Headlines
Shire snaps up CNS program from startup Heptares, commits $190M in 'biobucks'
Heptares Therapeutics has revealed another major tie-up with a big drugmaker. A unit of Ireland-based Shire ( $SHPGY ) has exercised an option to grab global rights to Heptares' preclinical...
Heptares raises $30M in Series A
Two-year-old Heptares Therapeutics raised $30.6 million in a Series A that will fund new research on drugs targeting G-protein-coupled receptors. Clarus Ventures led the syndicate for the UK biotech.
